The FDA issued a complete response letter for the BLA submission of subcutaneous amivantamab for EGFR-mutated NSCLC, citing ...

As we celebrate our 40th year, we continue to support filmmakers in our Artist Development Programs. Project Involve, the OG ...

WASHINGTON (AP) — The Commerce Department's efforts to curb China's and Russia's access to American-made advanced computer ...

YouTube creator Sean Hodgins debuted "Become Anyone 2.0," an updated version of a mask he designed that can project any face, ...

NEW ORLEANS (AP) — A judge sentenced a 93-year-old former Catholic priest Wednesday to spend the rest of his life behind bars ...

Taconic Capital Advisors is winding down its commercial real estate operation and is in advanced talks to sell one of the ...

In a letter to shareholders of the trusts on Dec. 18, Saba urged them to replace the boards, with Weinstein offering himself ...

A few days before my 10th Christmas, my younger siblings began to annoy me with their ranting about what Santa was going to bring them. Finally, I’d had enough. I ...

Conclusion: Adjudicating Authority didn’t commit any error in holding that all requisite conditions necessary to trigger CIRP ...

Move over, Wordle and Connections—there's a new NYT word game in town! The New York Times' recent game, "Strands," is becoming more and more popular as another daily activity fans can find on the NYT ...

Despite the recent FDA Complete Response Letter (CRL) for the subcutaneous version of amivantimab, Kapoor believes this does not significantly impact Halozyme’s future. The CRL is related to a ...